These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Third sacral foramina morphometry for sacral neuromodulation. McCullough MC; Decker S; Ford J; Downes K; Hilbelink D; Ordorica R; Hoyte L; Hart S Female Pelvic Med Reconstr Surg; 2013; 19(1):23-30. PubMed ID: 23321655 [TBL] [Abstract][Full Text] [Related]
7. First-in-human implantation of a mid-field powered neurostimulator at the sacral nerve: Results from an acute study. van Kerrebroeck PEVA; Reekmans M; van Koeveringe GA; Yeh AJ; Fayram TA; Sharan AD; Comiter CV Neurourol Urodyn; 2019 Aug; 38(6):1669-1675. PubMed ID: 31107559 [TBL] [Abstract][Full Text] [Related]
8. Strategies for Difficult Fluoroscopic Landmarking During Sacral Neuromodulation Lead Placement. Luchristt D; Amundsen CL Urology; 2023 Apr; 174():218-220. PubMed ID: 36638971 [TBL] [Abstract][Full Text] [Related]
9. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700 [TBL] [Abstract][Full Text] [Related]
10. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Peters KM; Killinger KA; Boura JA Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596 [TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation. Vaganée D; Kessler TM; Van de Borne S; De Win G; De Wachter S BJU Int; 2019 May; 123(5A):E7-E13. PubMed ID: 30537223 [TBL] [Abstract][Full Text] [Related]
12. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy. Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028 [TBL] [Abstract][Full Text] [Related]
14. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study. Kaaki B; Gupta D PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082 [TBL] [Abstract][Full Text] [Related]
15. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment. Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study. Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder. Ismail S; Chartier-Kastler E; Perrouin-Verbe MA; Rose-Dite-Modestine J; Denys P; Phé V Neuromodulation; 2017 Dec; 20(8):825-829. PubMed ID: 28967986 [TBL] [Abstract][Full Text] [Related]
18. To stage or not to stage?-A cost minimization analysis of sacral neuromodulation placement strategies. Sun AJ; Harris CR; Comiter CV; Elliott CS Neurourol Urodyn; 2019 Aug; 38(6):1783-1791. PubMed ID: 31215706 [TBL] [Abstract][Full Text] [Related]
19. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526 [TBL] [Abstract][Full Text] [Related]
20. A Cadaveric Study on the Efficacy of Surface Marking and Bony Landmarks Used in Sacral Neuromodulation. Almutairi S Cureus; 2020 Jul; 12(7):e9153. PubMed ID: 32676258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]